ABCs of Medical Management of Stones

$0.99

1.5for iPhone

Mission Pharmacal

Developer

Mar 22, 2016

Update Date

Medical

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

ABCs of Medical Management of Stones Screenshots

iPhone

ABCs of Medical Management of Stones poster

About ABCs of Medical Management of Stones

The ABCs of Medical Management of Stones App is an interactive tool designed to help simplify the complexities of managing kidney stone disease. Using a simple, step-by-step approach for the diagnosis and prevention of nephrolithiasis, the App guides you through patient screening and evaluation and provides treatment recommendations based on the consensus of the expert physician authors.

The App is also a handy reference tool when you need to look up information about dietary aberrations, stone-provoking medications, stone types, causes of urinary abnormalities, and more.

Download the ABCs of Medical Management of Stones App now for expert insight into the treatment and prevention of recurrent kidney stone formation.

Authors:
Margaret S. Pearle, MD
Glenn M. Preminger, MD
David S. Goldfarb, MD
Donald P. Griffith, MD
with
Charles Y.C. Pak, MD

All proceeds will be used for urology research and education. Supported by Mission Pharmacal Company.